Daunorubicin/cytarabine

Red

Brand Name(s):Vyxeos

Indication:Acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

Rationale:1,2

Considered:Aug-18

Review Date:Aug-23

Comments: